Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2893282rdf:typepubmed:Citationlld:pubmed
pubmed-article:2893282lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:2893282lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:2893282lifeskim:mentionsumls-concept:C0003286lld:lifeskim
pubmed-article:2893282lifeskim:mentionsumls-concept:C0016380lld:lifeskim
pubmed-article:2893282lifeskim:mentionsumls-concept:C0027410lld:lifeskim
pubmed-article:2893282lifeskim:mentionsumls-concept:C0039593lld:lifeskim
pubmed-article:2893282lifeskim:mentionsumls-concept:C0441472lld:lifeskim
pubmed-article:2893282lifeskim:mentionsumls-concept:C0022885lld:lifeskim
pubmed-article:2893282lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2893282lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:2893282lifeskim:mentionsumls-concept:C0115201lld:lifeskim
pubmed-article:2893282pubmed:dateCreated1988-3-18lld:pubmed
pubmed-article:2893282pubmed:abstractTextDynorphin A (1-13) acutely elevated the seizure threshold (ST) to the convulsant flurothyl, and this action was not blocked by naloxone. Increases in ST were also observed following i.c.v. injections of the non-opioid fragment dynorphin A (3-13). Pretreatment with dynorphin A (1-13), but not dynorphin A (3-13), non-competitively blocked the anticonvulsant effect of the mu selective opioid DAGO. Furthermore, pretreatment with dynorphin A (1-13) antagonized the delta antagonist properties of naloxone or ICI 154,129 in this seizure model. Thus, in addition to its non-opioid anticonvulsant effects, dynorphin A (1-13) exhibits unique antagonist actions which appear to be specific for the active opioid fragment.lld:pubmed
pubmed-article:2893282pubmed:languageenglld:pubmed
pubmed-article:2893282pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2893282pubmed:citationSubsetIMlld:pubmed
pubmed-article:2893282pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2893282pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2893282pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2893282pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2893282pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2893282pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2893282pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2893282pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2893282pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2893282pubmed:statusMEDLINElld:pubmed
pubmed-article:2893282pubmed:issn1046-9516lld:pubmed
pubmed-article:2893282pubmed:authorpubmed-author:HoladayJ WJWlld:pubmed
pubmed-article:2893282pubmed:authorpubmed-author:TortellaF CFClld:pubmed
pubmed-article:2893282pubmed:issnTypePrintlld:pubmed
pubmed-article:2893282pubmed:volume75lld:pubmed
pubmed-article:2893282pubmed:ownerNLMlld:pubmed
pubmed-article:2893282pubmed:authorsCompleteYlld:pubmed
pubmed-article:2893282pubmed:pagination539-42lld:pubmed
pubmed-article:2893282pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:2893282pubmed:meshHeadingpubmed-meshheading:2893282-...lld:pubmed
pubmed-article:2893282pubmed:meshHeadingpubmed-meshheading:2893282-...lld:pubmed
pubmed-article:2893282pubmed:meshHeadingpubmed-meshheading:2893282-...lld:pubmed
pubmed-article:2893282pubmed:meshHeadingpubmed-meshheading:2893282-...lld:pubmed
pubmed-article:2893282pubmed:meshHeadingpubmed-meshheading:2893282-...lld:pubmed
pubmed-article:2893282pubmed:meshHeadingpubmed-meshheading:2893282-...lld:pubmed
pubmed-article:2893282pubmed:meshHeadingpubmed-meshheading:2893282-...lld:pubmed
pubmed-article:2893282pubmed:meshHeadingpubmed-meshheading:2893282-...lld:pubmed
pubmed-article:2893282pubmed:meshHeadingpubmed-meshheading:2893282-...lld:pubmed
pubmed-article:2893282pubmed:meshHeadingpubmed-meshheading:2893282-...lld:pubmed
pubmed-article:2893282pubmed:meshHeadingpubmed-meshheading:2893282-...lld:pubmed
pubmed-article:2893282pubmed:meshHeadingpubmed-meshheading:2893282-...lld:pubmed
pubmed-article:2893282pubmed:year1986lld:pubmed
pubmed-article:2893282pubmed:articleTitleDynorphin A (1-13): in vivo opioid antagonist actions and non-opioid anticonvulsant effects in the rat flurothyl test.lld:pubmed
pubmed-article:2893282pubmed:affiliationDept. of Medical Neurosciences, Walter Reed Army Inst. of Res., Washington, D.C. 20307-5100.lld:pubmed
pubmed-article:2893282pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2893282lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2893282lld:pubmed